Mirae Asset Global Etfs Holdings Ltd. Entrada Therapeutics, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $41.5 Billion
- Q3 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Entrada Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 13,567 shares of TRDA stock, worth $269,847. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,567
Previous 11,389
19.12%
Holding current value
$269,847
Previous $162,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding TRDA
# of Institutions
101Shares Held
28.1MCall Options Held
34.5KPut Options Held
16.4K-
Baker Bros. Advisors LP New York, NY4.87MShares$96.8 Million0.83% of portfolio
-
Mpm Asset Management LLC Cambridge, MA4.43MShares$88 Million48.7% of portfolio
-
5 Am Venture Management, LLC San Francisco, CA4.41MShares$87.7 Million28.09% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.05MShares$60.7 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X01.71MShares$34 Million0.01% of portfolio
About Entrada Therapeutics, Inc.
- Ticker TRDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 31,368,500
- Market Cap $624M
- Description
- Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. The company's lead product candidate is ENTR-601-44, which is in precli...